Search results
Merck Prepares to Take on Pfizer After Pneumococcal Vaccine Approval
Barrons.com· 4 days agoPfizer currently dominates the market for pneumococcal vaccines, which protect against bacterial...
Merck’s vaccine approval poses threat to one of Pfizer’s top-selling products
Market Watch· 5 days ago“We’ll provide protection that’s broader than anything that’s out there,” Art Hirt, senior vice...
Merck & Co., Inc. (NYSE:MRK) Shares Bought by Aprio Wealth Management LLC
ETF DAILY NEWS· 8 hours agoAprio Wealth Management LLC boosted its stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 68.1% during the 1st quarter, according to its most recent Form 13F ...
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia,...
NBC New York· 5 days agoThe Food and Drug Administration approved Merck's vaccine designed to protect adults from a bacteria...
American National Bank Sells 1,072 Shares of Merck & Co., Inc. (NYSE:MRK)
ETF DAILY NEWS· 6 hours agoAmerican National Bank trimmed its holdings in Merck & Co., Inc. (NYSE:MRK – Free Report) by 3.5% in the 1st quarter, according to the company in its most ...
Merck wins FDA OK for vaccine rival to Pfizer’s pneumococcal shot
BioPharma Dive via Yahoo Finance· 4 days agoDive Insight: Merck currently sells two pneumococcal vaccines. One, dubbed Pneumovax 23, is for...
US FDA approves Merck's pneumococcal vaccine for adults
Reuters· 5 days ago, opens new tab said on Monday the U.S. Food and Drug Administration has approved its...
MSD competes with Pfizer in pneumococcal vaccine market after FDA approval
Pharmaceutical Technology via Yahoo Finance· 4 days agoGlobalData is the parent company of Pharmaceutical Technology. Among the clinical data supporting...